Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.24.17 extracted from

  • Alcaraz, L.A.; Banci, L.; Bertini, I.; Cantini, F.; Donaire, A.; Gonnelli, L.
    Matrix metalloproteinase-inhibitor interaction: the solution structure of the catalytic domain of human matrix metalloproteinase-3 with different inhibitors (2007), J. Biol. Inorg. Chem., 12, 1197-1206.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
3-(4'-cyanobiphenyl-4-yloxy)-N-hydroxypropionamide
-
Homo sapiens
N-hydroxy-2-[N-(2-hydroxyethyl)biphenyl-4-sulfonamide] hydroxamic acid
-
Homo sapiens
N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid
-
Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Specific Activity [micromol/min/mg]

Specific Activity Minimum [µmol/min/mg] Specific Activity Maximum [µmol/min/mg] Comment Organism
0.000498
-
-
Homo sapiens

Ki Value [mM]

Ki Value [mM] Ki Value maximum [mM] Inhibitor Comment Organism Structure
0.00018
-
N-hydroxy-2-[N-(2-hydroxyethyl)biphenyl-4-sulfonamide] hydroxamic acid
-
Homo sapiens
0.00025
-
3-(4'-cyanobiphenyl-4-yloxy)-N-hydroxypropionamide
-
Homo sapiens
0.0013
-
N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid
-
Homo sapiens